Hepatobiliary and Pancreatic Surgery

Complexity defines the scope of hepatobiliary and pancreatic surgery, where anatomical challenges and perioperative risks demand meticulous planning. Advances in imaging, surgical navigation, and oncologic criteria have improved resectability in liver and pancreatic tumors previously deemed inoperable. Surgeons are now able to perform anatomical liver segmentectomies, bile duct reconstructions, and minimally invasive pancreatic resections with reduced complications. Enhanced preoperative staging and protocols like ERAS have significantly improved postoperative outcomes. In cases of cholangiocarcinoma or pancreatic cancer, integrating surgical expertise with neoadjuvant therapy and molecular profiling has become central to extending survival. The growing use of robotic assistance and vascular reconstruction further pushes the boundaries of what’s operable. With collaborative input from oncology, hepatology, and transplant teams, the field is moving toward more personalized and curative interventions for diseases that once carried poor prognoses.